Navigation Links
Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev
Date:1/8/2008

The Initiative, Based on Advanced WiMAX Broadband Wireless Technology, Will Provide Free Internet Access to Kindergartens, Elementary Schools and the

Sapir Community College

PETACH TIKVA, Israel, January 8 /PRNewswire-FirstCall/ -- 012 Smile.Communications (NASDAQ:SMLC) (TASE:SMLC), a growth-oriented provider of communication services in Israel, today announced that it has joined with Israel's Ministry of Communications, Intel Corporation (NYSE: INTC) and Alvarion Ltd. (NASDAQ: ALVR), in launching a WiMAX project as an expression of solidarity with the residents of Sderot, Israel and the entire Western Negev region due to the security situation in the region. Following approvals by the Israel's Ministry of Communication, 012 Smile, Intel and Alvarion have undertaken a state-of-the-art initiative, the first of its kind in Israel and one of the first in the world, to establish WiMAX wireless-based Internet coverage in this Southern region of Israel.

The Sderot project will allow students and others to surf the Web without cost and enjoy high-quality and continuous use of WiMAX technology, one of the most innovative and advanced wireless technologies in the world. The ultimate goal of the project is to enable local citizens to enjoy wireless broadband surfing an
'/>"/>

SOURCE 012 Smile.communications Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
5. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
6. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
7. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. FRC Applauds New Ballot Initiative for Cures Without Cloning
10. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
11. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
(Date:3/3/2015)... DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - Aptose ... developing new therapeutics and molecular diagnostics that target the ... the quarter and seventh-month period ended December 31, 2014. ... its fiscal year end from May 31 to December ... we are reporting today are for the quarter and ...
(Date:3/3/2015)... 2015 NASA astronaut Scott Kelly , who ... spend a year living and working on the International Space ... to 7 a.m. EDT Monday, March 9. Kelly ... completes the final weeks of his training. The interviews will ... Television highlighting his mission training and previous spaceflights. ...
Breaking Biology Technology:Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... 20 Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), ... products using its proprietary transdermal delivery platform, today announced ... of Transdel, will present a company overview at ... the 4th annual BIOCOM Investor Conference in San Diego, ...
... ATLANTA, Oct. 20 GeoVax Labs, Inc. ... "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for ... infectious agents, today announced that it will move its ... of Emory University to Smyrna, Georgia, a northwest suburb ...
... ... ways to make organic gardening simple, safe and fun. , ... Boston, MA (PRWEB) October 19, 2009 -- It,s no longer ... naturally. As a matter of fact, "as the demand for healthy, fresh fruits and veggies ...
Cached Biology Technology:Transdel Pharmaceuticals to Present at Two Investor Conferences 2Transdel Pharmaceuticals to Present at Two Investor Conferences 3GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 2GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 3GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 4The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 3
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... far too much salt, and a University of Iowa researcher ... put us in a better mood. UI psychologist Kim ... are deficient in sodium chloride, common table salt, they shy ... substance or pressing a bar that stimulates a pleasant sensation ...
... states the case for protecting the species in ... , recently published by Harvard University Press. ... Bianca Perla, a University of Washington ecologist, and Jennifer ... New York in Stony Brook, shows that animals are ...
... at Children,s National Medical Center have identified ... suffering from sepsis: platelets. The finding, published ... Care Medicine , is the first time doctors have ... this often fatal infection. "Despite many medical ...
Cached Biology News:Study suggests salt might be 'nature's antidepressant' 2Study suggests salt might be 'nature's antidepressant' 3Prairie dog research promotes caring, conservation 2Children's National research links platelets to sepsis-related organ failure 2
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Goat polyclonal to Als2 ( Abpromise for all tested applications). entrezGeneID: 57679 SwissProtID: Q96Q42...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: